PubMed · 1994 · 35 citations · 16 references
Life SciencesCell BiologyOncologyApoptosisCancer ImmunologyMolecular OncologyApoptosis In CancerApoptosis RegulationApoptosis ResistanceBcl-2 Family ProteinsCancer Cell SignalingCytotoxic T Lymphocyte ResponsesBcl-2 Family DysregulationBcl-2 InhibitionBcl-2 Protein ExpressionBcl-2 Protein RegulationBcl2 Inhibition
The bcl-2 gene becomes dysregulated in its expression in a wide variety of human cancers and has been shown to block both spontaneous and drug-induced cell death, thus conferring a selective survival advantage on malignant cells. The biochemical mechanism by which bcl-2 promotes cell survival remains enigmatic but appears to involve a downstream event in an evolutionarily conserved cell death pathway. Here we report that gene transfer-mediated increases in Bcl-2 protein levels in the human leukemia line Jurkat render these cells more resistant to induction of DNA fragmentation and cytolysis by a cloned T-cell. The killing mechanism used by these particular T-cells was consistent with apoptosis, as opposed to necrosis, in that DNA degradation occurred as a prelysis event. The findings raise the possibility that dysregulation of bcl-2 gene expression could play a role in the avoidance of immune surveillance mechanisms by cancer cells.
16
Elizabeth A. Grimm, A Mazumder, H Z Zhang et al. · The Journal of Experimental Medicine · 1982 · 2.2K citations · Full text
Life Sciences, Immunology, Oncology +15
Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line
Toshiyuki Miyashita, JC Reed · Blood · 1993 · 876 citations · Full text
Medicine, Cancer Biology, Oncology +13